Author

Nicholas J. Keeling

Observed names: N. Keeling, Nicholas J Keeling

Institution: University of Mississippi

Observed institutions: St. Jude Children's Research Hospital, University of Mississippi

OpenAlex ID: A5057423193

Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers

2017 · Nicholas J. Keeling, Meagen M. Rosenthal, et al. · Genetics in Medicine · 81

Standardization Can Accelerate the Adoption of Pharmacogenomics: Current Status and the Path Forward

2018 · Kelly E Caudle, Nicholas J Keeling, et al. · Pharmacogenomics · 69

Priorities for Pediatric Patient Safety Research

2019 · James M. Hoffman, Nicholas J. Keeling, et al. · PEDIATRICS · 57

PARC report: A Health-Systems Focus on Reimbursement and Patient Access to Pharmacogenomics Testing

2020 · Sara L Rogers, Nicholas J Keeling, et al. · Pharmacogenomics · 32

Approaches to assessing the provider experience with clinical pharmacogenomic information: a scoping review

2021 · Nicholas J. Keeling, Tyler J. Dunn, et al. · Genetics in Medicine · 10

Cost-Effectiveness Of Once Daily Dolutegravir Versus Twice Daily Raltegravir As First-Line Antiretroviral Therapy In Hiv-Infected Adults In The United States

2014 · N. Keeling, A. Crumby, et al. · Value in Health · 1

A Sustainable Future In The Implementation Of Clinical Pharmacogenomics

2019 · Nicholas J. Keeling

Payer Perspectives On Preemptive Pharmacogenetic Testing

2016 · Nicholas J. Keeling

Works count: 8

Citation count: 250

H-index: 5

I10-index: 5